A Multidisciplinary Certified Primary Stroke Center: From Bedside to the Community
- 'The whole story'. Hunter, Kathryn Montgom // Second Opinion;Oct93, Vol. 19 Issue 2, p96
Presents an overview of the story of stroke patient Martin Lubell who died in a nursing home. Point of view of four doctors, a social worker and a medical student; Story as an ideal; Principles-based ethics; Criticisms on medical cases.
- Sea change expected in hospital treatment of stroke. Carrell, Steve // Drug Topics;2/19/96, Vol. 140 Issue 4, p48
Focuses on the hoopla over a federal study showing t-PA as the first treatment for acute stroke. Hospitals' need for coordinated treatment teams; Cost of the new treatment; Other studies presented at the American Heart Association's 1996 stroke conference.
- Avoiding a second stroke: Two drugs may help. McCann, Jean // Drug Topics;2/19/96, Vol. 140 Issue 4, p52
Focuses on a European multicenter study suggesting that a combination of sustained-release dipyridamole and low-dose aspirin can reduce the risk of a second stroke. Administration of combination antiplatelet therapy in secondary stroke prevention; Doctor Hans-Christoph Diener's presentation at...
- Stroke: Every minute counts. // Consumer Reports on Health;Jul93, Vol. 5 Issue 7, p78
Claims that the first six hours after a stroke offers the best chance of successful treatment according to the National Stroke Association. Warning signs of a stroke.
- Prophylactic drug therapy in cerebrovascular disease. Unwin, D. Hal; Greenlee Jr., Ralph G. // American Family Physician;7/1/1993, Vol. 48 Issue 1, p85
Discusses the prophylactic drug therapy in cerebrovascular disease. Prophylaxis regimens and outcomes of aspirin; Dipyridamole and sulfinpyrazone; Efficacy and adverse effects of ticlopidine; Role of warfarin in ischemic cerebrovascular disease.
- Different strokes. Anderson, Eric D. // Patient Care;2/28/1997, Vol. 31 Issue 4, p13
Editorial. Talks on the benefits of giving recombinant tissue plasminogen activator (r-TPA) in the treatment of strokes. Economic advantage of r-TPA; Basic difference between heart attack and stroke; Medical cost of different treatment methods for stroke in the United States.
- A confusing message about aspirin in stroke. Pinkowish, Mary Desmond // Patient Care;8/15/1997, Vol. 31 Issue 13, p29
Provides information on the results of a study on the effects of aspirin in stroke treatment and prevention according to the Chinese Acute Stroke Trial (CAST) and the parallel International Stroke Trial (IST). Findings of the study; Comments from Dr. Alberts, director of the Stroke Acute Care...
- Healing strokes. // Prevention;Nov93, Vol. 45 Issue 11, p10
Tells how friendship can speed recovery from a stroke. Study results of 46 first-time stroke patients showing that patients who thought they got the most TLC from friends and family recovered best. Study co-author Thomas A. Glass; Guidelines to caregivers.
- Hope for fighting stroke. Watson, Traci // U.S. News & World Report;2/20/95, Vol. 118 Issue 7, p67
Discusses stroke, which ranks third in number of deaths caused in America. Reports by European research team that the drug TPA dramatically benefits stroke patients; Huge drawbacks of TPA; Study of a drugs including lubeluzole, Cerestat and 619c89.
- Prompt medical care is needed to prevent severe stroke damage. // Hudson Valley Business Journal;03/30/98, Vol. 8 Issue 24, p21
Provides an overview on the information issued by the Poughkeepsie, New York Vassar Hospital on the need to treat stroke victims. Incidence of the disease; Signs and symptoms; Emergency management.